Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to equity ratio high or low?
The debt to equity ratio of 2.02 is 137% above its 2-year average of -5.39, around the middle of its 2-year range (-106.77–152.48).
As of the fiscal period ended Tuesday, June 30, 2026. 80.93% below its 12-month average of 10.57.
Reported quarterly debt to equity ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 2.02.
DEBT TO EQUITY RATIO
2.02
DEBT TO EQUITY RATIO AVG TTM
10.57
DEBT TO EQUITY RATIO AVG 3Y
N/A
DEBT TO EQUITY RATIO AVG 5Y
N/A
DEBT TO EQUITY RATIO AVG 10Y
N/A
DEBT TO EQUITY RATIO AVG 15Y
N/A
DEBT TO EQUITY RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-80.93%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11
median of 742 covered companies
CURRENT VS SECTOR MEDIAN
+1732.11%
vs the sector median at left
Park Dental Partners, Inc. Common Stock
Market Cap
$93.01M
Debt to Equity Ratio
2.02
TTM Avg
10.57
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$90.37M
Debt to Equity Ratio
0.07
TTM Avg
0.11
3Y Avg
0.07
5Y Avg
0.06
Market Cap
$90.32M
Debt to Equity Ratio
0.00
TTM Avg
0.00
3Y Avg
0.00
5Y Avg
0.00
Market Cap
$89.84M
Debt to Equity Ratio
0.40
TTM Avg
0.52
3Y Avg
0.53
5Y Avg
0.47
Market Cap
$96.51M
Debt to Equity Ratio
7.79
TTM Avg
2.79
3Y Avg
2.17
5Y Avg
1.45
Market Cap
$89.33M
Debt to Equity Ratio
0.00
TTM Avg
0.01
3Y Avg
0.04
5Y Avg
0.03
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Park Dental Partners, Inc. Common Stock (PARK) | $93.01M | 2.02 | 10.57 | N/A | N/A |
| electroCore, Inc. (ECOR)vs › | $89.71M | N/A | 0.32 | 0.17 | 0.15 |
| Equillium, Inc. (EQ)vs › | $91.05M | 0.01 | 0.03 | 0.10 | 0.12 |
| Biomea Fusion, Inc. (BMEA)vs › | $90.37M | 0.07 | 0.11 | 0.07 | 0.06 |
| Rallybio Corporation (RLYB)vs › | $90.32M | 0.00 | 0.00 | 0.00 | 0.00 |
| ImmuCell Corporation (ICCC)vs › | $89.84M | 0.40 | 0.52 | 0.53 | 0.47 |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $96.51M | 7.79 | 2.79 | 2.17 | 1.45 |
| PMV Pharmaceuticals, Inc. (PMVP)vs › | $89.33M | 0.00 | 0.01 | 0.04 | 0.03 |
| Korro Bio, Inc. (KRRO)vs › | $96.75M | 0.41 | 0.56 | 0.44 | 0.38 |
| Conexeu Sciences Inc. (CNXU)vs › | $97.13M | N/A | N/A | N/A | N/A |
Debt/Equity
2.02
Current Ratio
1.12
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2026-06-30 | 2.02 |
| 2026-03-31 | 2.35 |
| 2025-12-31 | 2.77 |
| 2025-09-30 | 152.48 |
| 2025-06-30 | -106.77 |
| 2025-03-31 | -106.77 |
| 2024-12-31 | 0.00 |
| 2024-09-30 | 0.00 |
| 2024-06-30 | 0.00 |
| 2024-03-31 | 0.00 |
